The Promoter Group Entity M/s Lenus Finvest Private Limited received an adjudication order dated 05/01/2026 from SEBI for the alleged non-compliance with Regulation 31 of SAST Regulations ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Eiko Lifesciences Ltd informed the stock exchange that its Promoter Group entity, Lenus Finvest Private Limited, received a SEBI adjudication order dated 05 January 2026 for alleged non-compliance with Regulation 31 of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, related to transactions between November 2019 and June 2021. SEBI levied a penalty of Rs. 1,00,000 (One Lakh) on the promoter entity for non-disclosure of Margin Pledge by the concerned Depository Participant. The company clarified that this order has no financial or operational impact on Eiko Lifesciences. The promoter group entity plans to explore legal options to challenge the order.
The penalty is on the promoter group entity (not the listed company directly) and is small in size, with management confirming no material financial or operational impact. However, governance concerns around the promoter group and potential reputational risk may weigh mildly on investor sentiment.